Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Appropriate use criteria for optical coherence tomography guidance in percutaneous coronary interventions : Recommendations of the working group of interventional cardiology of the Netherlands Society of Cardiology.

IJsselmuiden AJJ, Zwaan EM, Oemrawsingh RM, Bom MJ, Dankers FJWM, de Boer MJ, Camaro C, van Geuns RJM, Daemen J, van der Heijden DJ, Jukema JW, Kraaijeveld AO, Meuwissen M, Schölzel BE, Pundziute G, van der Harst P, van Ramshorst J, Dirksen MT, Zivelonghi C, Agostoni P, van der Heyden JAS, Wykrzykowska JJ, Scholte MJ, Nef HM, Kofflard MJM, van Royen N, Alings M, Kedhi E.

Neth Heart J. 2018 Oct;26(10):473-483. doi: 10.1007/s12471-018-1143-z. Review.

2.

Addition of routinely measured blood biomarkers significantly improves GRACE risk stratification in patients with myocardial infarction.

van Toorenburg M, van den Berg VJ, van der Ploeg T, Heestermans AA, Dirksen MT, Hautvast RW, Drexhage O, Boersma E, Kardys I, Umans VAWM.

Int J Cardiol. 2018 Dec 15;273:237-242. doi: 10.1016/j.ijcard.2018.07.100. Epub 2018 Jul 21.

PMID:
30055951
3.

Parasitic stool testing in newly arrived refugees in Calgary, Alta.

DeVetten G, Dirksen M, Weaver R, Chowdhury TT, Aucoin MW.

Can Fam Physician. 2017 Dec;63(12):e518-e525.

4.

Recurrent Myocardial Infarction After Primary Percutaneous Coronary Intervention in Multivessel Coronary Disease Is Primarily Related to Stent Failure: Post-Hoc Analysis of the PASSION Trial.

Vink MA, Vos NS, Dirksen MT, Suttorp MJ, Slagboom T, Patterson MS, Kiemeneij F, Laarman G.

J Interv Cardiol. 2015 Dec;28(6):523-30. doi: 10.1111/joic.12246.

PMID:
26643000
5.

Safety and feasibility of a PAclitaxel-eluting balloon angioplasty in Primary Percutaneous coronary intervention in Amsterdam (PAPPA): one-year clinical outcome of a pilot study.

Vos NS, Dirksen MT, Vink MA, van Nooijen FC, Amoroso G, Herrman JP, Kiemeneij F, Patterson MS, Slagboom T, van der Schaaf RJ.

EuroIntervention. 2014 Sep;10(5):584-90. doi: 10.4244/EIJV10I5A101.

6.

Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials.

De Luca G, Dirksen MT, Kelbæk H, Thuesen L, Vink MA, Kaiser C, Chechi T, Spaziani G, Di Lorenzo E, Suryapranata H, Stone GW.

J Thromb Thrombolysis. 2015 Jan;39(1):101-12. doi: 10.1007/s11239-014-1091-4. Review.

PMID:
24968748
7.

Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: insights from the DESERT cooperation.

De Luca G, Dirksen MT, Spaulding C, Kelbæk H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Diaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW; DESERT cooperation.

Int J Cardiol. 2014 Jul 15;175(1):50-4. doi: 10.1016/j.ijcard.2014.04.180. Epub 2014 Apr 26.

PMID:
24852835
8.

Drug-eluting stents in patients with anterior STEMI undergoing primary angioplasty: a substudy of the DESERT cooperation.

De Luca G, Dirksen MT, Spaulding C, Kelbæk H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW.

Clin Res Cardiol. 2014 Sep;103(9):685-99. doi: 10.1007/s00392-014-0702-6. Epub 2014 Apr 1.

PMID:
24687617
9.

Gender-related differences in outcome after BMS or DES implantation in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: insights from the DESERT cooperation.

De Luca G, Verdoia M, Dirksen MT, Spaulding C, Kelbæk H, Schalij M, Thuesen L, Hoeven Bv, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Diaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW; DESERT Cooperation.

Atherosclerosis. 2013 Sep;230(1):12-6. doi: 10.1016/j.atherosclerosis.2013.05.024. Epub 2013 Jun 27.

PMID:
23958246
10.

Time course, predictors and clinical implications of stent thrombosis following primary angioplasty. Insights from the DESERT cooperation.

De Luca G, Dirksen MT, Spaulding C, Kelbæk H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Diaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW; DESERT cooperation.

Thromb Haemost. 2013 Oct;110(4):826-33. doi: 10.1160/TH13-02-0092. Epub 2013 Jul 18.

PMID:
23864101
11.

Impact of age on long-term outcome after primary angioplasty with bare-metal or drug-eluting stent (from the DESERT cooperation).

De Luca G, Dirksen MT, Spaulding C, Kelbæk H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Diaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW; DESERT cooperation.

Am J Cardiol. 2013 Jul 15;112(2):181-6. doi: 10.1016/j.amjcard.2013.03.012. Epub 2013 May 7.

PMID:
23664294
12.

Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary intervention.

De Luca G, Dirksen MT, Spaulding C, Kelbæk H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Diaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW; DESERT Cooperation.

Am J Cardiol. 2013 May 1;111(9):1295-304. doi: 10.1016/j.amjcard.2013.01.281. Epub 2013 Mar 12. Review.

PMID:
23490029
13.

Impact of diabetes on long-term outcome after primary angioplasty: insights from the DESERT cooperation.

De Luca G, Dirksen MT, Spaulding C, Kelbæk H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Diaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW; DESERT cooperation.

Diabetes Care. 2013 Apr;36(4):1020-5. doi: 10.2337/dc12-1507. Epub 2012 Dec 28.

14.

Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.

De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Díaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Cortese G, Suryapranata H, Stone GW; Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation.

Arch Intern Med. 2012 Apr 23;172(8):611-21; discussion 621-2. doi: 10.1001/archinternmed.2012.758. Review.

PMID:
22529227
15.

Routine use of the transradial approach in primary percutaneous coronary intervention: procedural aspects and outcomes in 2209 patients treated in a single high-volume centre.

Vink MA, Amoroso G, Dirksen MT, van der Schaaf RJ, Patterson MS, Tijssen JG, Kiemeneij F, Slagboom T.

Heart. 2011 Dec;97(23):1938-42. doi: 10.1136/heartjnl-2011-300524. Epub 2011 Aug 31.

PMID:
21880651
16.

Patency of paclitaxel-eluting versus bare metal stents long term after implantation in acute ST-segment elevation myocardial infarction.

Vink MA, Van Nooijen FC, Laarman GJ, Suttorp MJ, Tijssen JG, Slagboom T, Patterson MS, Van Der Schaaf RJ, Kiemeneij F, Amoroso G, Dirksen MT.

Am J Cardiol. 2011 Nov 1;108(9):1214-9. doi: 10.1016/j.amjcard.2011.06.034. Epub 2011 Aug 23.

PMID:
21864813
17.

Lack of long-term clinical benefit of thrombus aspiration during primary percutaneous coronary intervention with paclitaxel-eluting stents or bare-metal stents: post-hoc analysis of the PASSION-trial.

Vink MA, Dirksen MT, Tijssen JG, Suttorp MJ, Patterson MS, van Geloven N, Ijsselmuiden AJ, Slagboom T, Kiemeneij F, Laarman GJ.

Catheter Cardiovasc Interv. 2012 May 1;79(6):870-7. doi: 10.1002/ccd.23226. Epub 2011 Dec 12.

PMID:
21735533
18.

A randomized comparison of manual versus mechanical thrombus removal in primary percutaneous coronary intervention in the treatment of ST-segment elevation myocardial infarction (TREAT-MI).

Vink MA, Patterson MS, van Etten J, Ijsselmuiden AJ, Dirksen MT, Amoroso G, Slagboom T, Laarman G, Kiemeneij F.

Catheter Cardiovasc Interv. 2011 Jul 1;78(1):14-9. doi: 10.1002/ccd.22932.

PMID:
21681888
20.

Primary percutaneous coronary intervention by magnetic navigation compared with conventional wire technique.

Patterson MS, Dirksen MT, Ijsselmuiden AJ, Amoroso G, Slagboom T, Laarman GJ, Schultz C, van Domburg RT, Serruys PW, Kiemeneij F.

Eur Heart J. 2011 Jun;32(12):1472-8. doi: 10.1093/eurheartj/ehp587. Epub 2010 Jan 4.

PMID:
20051425
21.

Hotline sessions of the 31st European Congress of Cardiology.

Evertz R, van Bennekom S, Dirksen MT, Verheugt FW.

Eur Heart J. 2009 Nov;30(21):2562-5. doi: 10.1093/eurheartj/ehp432. Epub 2009 Oct 13. No abstract available.

PMID:
19828472
22.

Early discharge after primary percutaneous coronary intervention.

Laarman GJ, Dirksen MT.

Heart. 2010 Apr;96(8):584-7. doi: 10.1136/hrt.2009.171363. Epub 2009 Sep 23. Review.

PMID:
19778921
23.

Comparison of magnetically navigated and conventional wire percutaneous coronary intervention of a single discrete stenosis.

Patterson MS, van Nooijen F, Ijsselmuiden A, Dirksen M, Van Domburg R, Serruys P, Kiemeneij F.

Catheter Cardiovasc Interv. 2009 Nov 1;74(5):693-9. doi: 10.1002/ccd.22117.

PMID:
19496121
24.

Magnetically navigated percutaneous coronary intervention in distal and/or complex lesions may improve procedural outcome and material consumption.

IJsselmuiden AJ, Patterson MS, van Nooijen FC, Tangelder GJ, Dirksen MT, Amoroso G, Slagboom T, Serruys PW, Laarman GJ, Kiemeneij F.

EuroIntervention. 2009 Jan;4(4):517-23.

PMID:
19284075
25.

Two year follow-up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up study.

Dirksen MT, Vink MA, Suttorp MJ, Tijssen JG, Patterson MS, Slagboom T, Kiemeneij F, Laarman GJ; Paclitaxel-Eluting Stent versus Conventional Stent; in Myocardial Infarction with ST-Segment Elevation (PASSION) investigators.

EuroIntervention. 2008 May;4(1):64-70.

PMID:
19112781
26.

A 3-D active shape model driven by fuzzy inference: application to cardiac CT and MR.

van Assen HC, Danilouchkine MG, Dirksen MS, Reiber JH, Lelieveldt BP.

IEEE Trans Inf Technol Biomed. 2008 Sep;12(5):595-605. doi: 10.1109/TITB.2008.926477.

PMID:
18779074
27.

Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis.

Stettler C, Allemann S, Wandel S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, De Carlo M, Erglis A, Chechi T, Ortolani P, Schalij MJ, Diem P, Meier B, Windecker S, Jüni P.

BMJ. 2008 Aug 29;337:a1331. doi: 10.1136/bmj.a1331. Review.

28.

Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.

De Luca G, Stone GW, Suryapranata H, Laarman GJ, Menichelli M, Kaiser C, Valgimigli M, Di Lorenzo E, Dirksen MT, Spaulding C, Pittl U, Violini R, Percoco G, Marino P.

Int J Cardiol. 2009 Apr 3;133(2):213-22. doi: 10.1016/j.ijcard.2007.12.040. Epub 2008 Apr 3.

PMID:
18394731
29.

Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.

Kastrati A, Dibra A, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Seyfarth M, Varenne O, Dirksen MT, Percoco G, Varricchio A, Pittl U, Syvänne M, Suttorp MJ, Violini R, Schömig A.

Eur Heart J. 2007 Nov;28(22):2706-13. Epub 2007 Sep 27. Review.

PMID:
17901079
30.

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.

Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Jüni P.

Lancet. 2007 Sep 15;370(9591):937-48. Review.

PMID:
17869634
31.

Differences in plaque composition and distribution in stable coronary artery disease versus acute coronary syndromes; non-invasive evaluation with multi-slice computed tomography.

Schuijf JD, Beck T, Burgstahler C, Jukema JW, Dirksen MS, de Roos A, van der Wall EE, Schroeder S, Wijns W, Bax JJ.

Acute Card Care. 2007;9(1):48-53.

PMID:
17453539
32.

Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies.

Dirksen MT, Laarman GJ, Simoons ML, Duncker DJ.

Cardiovasc Res. 2007 Jun 1;74(3):343-55. Epub 2007 Jan 23. Review.

PMID:
17306241
33.

Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-Elevation Myocardial Infarction: the randomized multicentre CASTEMI study.

Bär FW, Tzivoni D, Dirksen MT, Fernández-Ortiz A, Heyndrickx GR, Brachmann J, Reiber JH, Avasthy N, Tatsuno J, Davies M, Hibberd MG, Krucoff MW; CASTEMI Study Group.

Eur Heart J. 2006 Nov;27(21):2516-23. Epub 2006 Oct 9.

PMID:
17030521
34.

Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention.

Laarman GJ, Suttorp MJ, Dirksen MT, van Heerebeek L, Kiemeneij F, Slagboom T, van der Wieken LR, Tijssen JG, Rensing BJ, Patterson M.

N Engl J Med. 2006 Sep 14;355(11):1105-13.

35.

Early discharge is feasible following primary percutaneous coronary intervention with transradial stent implantation under platelet glycoprotein IIb/IIIa receptor blockade. Results of the AGGRASTENT Trial.

Dirksen MT, Ronner E, Laarman GJ, van Heerebeek L, Slagboom T, van der Wieken LR, van der Wouw PA, Kiemeneij F.

J Invasive Cardiol. 2005 Oct;17(10):512-7.

PMID:
16204742
36.

Cardiac multidetector-row computed tomography in patients with unstable angina.

Dirksen MS, Jukema JW, Bax JJ, Lamb HJ, Boersma E, Tuinenburg JC, Geleijns J, van der Wall EE, de Roos A.

Am J Cardiol. 2005 Feb 15;95(4):457-61.

PMID:
15695128
37.

Multislice computed tomography versus intracardiac echocardiography to evaluate the pulmonary veins before radiofrequency catheter ablation of atrial fibrillation: a head-to-head comparison.

Jongbloed MR, Bax JJ, Lamb HJ, Dirksen MS, Zeppenfeld K, van der Wall EE, de Roos A, Schalij MJ.

J Am Coll Cardiol. 2005 Feb 1;45(3):343-50.

38.

Atrial fibrillation: multi-detector row CT of pulmonary vein anatomy prior to radiofrequency catheter ablation--initial experience.

Jongbloed MR, Dirksen MS, Bax JJ, Boersma E, Geleijns K, Lamb HJ, van der Wall EE, de Roos A, Schalij MJ.

Radiology. 2005 Mar;234(3):702-9. Epub 2005 Jan 21.

PMID:
15665218
39.

Coronary stent imaging with multidetector row computed tomography.

Schuijf JD, Bax JJ, Jukema JW, Lamb HJ, Dirksen MS, van der Wall EE, de Roos A.

Int J Cardiovasc Imaging. 2004 Aug;20(4):341-4.

PMID:
15529920
40.

Xenopus flotillin1, a novel gene highly expressed in the dorsal nervous system.

Pandur PD, Dirksen ML, Moore KB, Moody SA.

Dev Dyn. 2004 Dec;231(4):881-7.

41.

Long-term survival in a case of unoperated single ventricle.

Restaino G, Dirksen MS, de Roos A.

Int J Cardiovasc Imaging. 2004 Jun;20(3):221-5.

PMID:
15139537
42.

The effect of ITF-1697 on reperfusion in patients undergoing primary angioplasty. Safety and efficacy of a novel tetrapeptide, ITF-1697.

Dirksen MT, Laarman G, van 't Hof AW, Guagliumi G, Tonino WA, Tavazzi L, Duncker DJ, Simoons ML; PARI-MI Investigators (Protect Against Reperfusion Injury with ITF-1697 in acute Myocardial Infarction).

Eur Heart J. 2004 Mar;25(5):392-400.

PMID:
15033251
43.

Images in cardiovascular medicine. Dynamic multislice computed tomography of left ventricular function.

Dirksen MS, Bax JJ, de Roos A, Jukema JW, van der Geest RJ, Geleijns J, van der Wall EE, Lamb HJ.

Circulation. 2004 Feb 3;109(4):e25-6. No abstract available.

PMID:
14757685
44.

Three-dimensional navigator coronary MRA with the aid of a blood pool agent in pigs: improved image quality with inclusion of the contrast agent first-pass.

Dirksen MS, Kaandorp TA, Lamb HJ, Doornbos J, Corot C, de Roos A.

J Magn Reson Imaging. 2003 Oct;18(4):502-6.

PMID:
14508788
45.

Toward comparability of coronary magnetic resonance angiography: proposal for a standardized quantitative assessment.

Dirksen MS, Lamb HJ, van der Geest R, de Roos A.

Eur Radiol. 2003 Oct;13(10):2353-7. Epub 2003 Aug 2.

PMID:
12904884
46.

Comparison of MSCT and MRA in the evaluation of an anomalous right coronary artery.

Salm LP, Bax JJ, Dirksen MS, Vliegen HW, Jukema JW, Schalij MJ, van der Wall EE, Lamb HJ.

J Cardiovasc Magn Reson. 2003;5(2):403-5. No abstract available.

PMID:
12765119
47.

Coronary magnetic resonance angiography: technical developments and clinical applications.

Dirksen MS, Lamb HJ, Doornbos J, Bax JJ, Jukema JW, de Roos A.

J Cardiovasc Magn Reson. 2003;5(2):365-86. Review.

PMID:
12765116
48.

Improved MR coronary angiography with use of a new rapid clearance blood pool contrast agent in pigs.

Dirksen MS, Lamb HJ, Kunz P, Robert P, Corot C, de Roos A.

Radiology. 2003 Jun;227(3):802-8. Epub 2003 Apr 3.

PMID:
12676975
49.

Radiofrequency catheter ablation of paroxysmal atrial fibrillation; guidance by intracardiac echocardiography and integration with other imaging techniques.

Jongbloed MR, Bax JJ, de Groot NM, Dirksen MS, Lamb HJ, de Roos A, van der Wall EE, Schalij MJ.

Eur J Echocardiogr. 2003 Mar;4(1):54-8. No abstract available.

PMID:
12565063
50.

Detection of malignant right coronary artery anomaly by multi-slice CT coronary angiography.

Dirksen MS, Bax JJ, Blom NA, Schalij MJ, Jukema WJ, Vliegen HW, van der Wall EE, de Roos A, Lamb HJ.

Eur Radiol. 2002 Dec;12 Suppl 3:S177-80. Epub 2002 May 14.

PMID:
12522635

Supplemental Content

Loading ...
Support Center